MedPath
HSA Approval

NAZAL SPRAY

SIN03722P

NAZAL SPRAY

NAZAL SPRAY

November 6, 1989

SATO PHARMACEUTICAL (SINGAPORE) PTE LTD

SATO PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSATO PHARMACEUTICAL (SINGAPORE) PTE LTD
Licence HolderSATO PHARMACEUTICAL (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SPRAY

NASAL

Medical Information

R01AB02

naphazoline

Manufacturer Information

SATO PHARMACEUTICAL (SINGAPORE) PTE LTD

SATO PHARMACEUTICAL CO LTD

Active Ingredients

CHLORPHENIRAMINE MALEATE

500 mg/100 ml

Chlorpheniramine

NAPHAZOLINE HCl

50 mg/100 ml

Naphazoline

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.